Showing 1,641 - 1,660 results of 105,653 for search '(( a fold decrease ) OR ( 5 ((((step decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.62s Refine Results
  1. 1641

    Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

    Published 2013
    “…<p>Rh4 and RMS13 cells were treated for 24 hours (A) and 48 hours (B) with different concentrations of fenretinide (0.5–1–5 µM, as indicated). …”
  2. 1642
  3. 1643

    (A) Decreased DNA CpG methylation at the CpG island of the gene locus in Th2 cells by Masakatsu Yamashita (46657)

    Published 2011
    “…MeDIP assay was performed using an anti–5-methyl cytidine antibody (5-meC) and a control antibody (Cont.). …”
  4. 1644
  5. 1645

    Decreased remyelination initiation is observed in Scribble cKO mice following focal demyelination in corpus callosum. by Andrew A. Jarjour (343100)

    Published 2015
    “…In the contralateral (unlesioned) hemisphere (CL), no difference was seen in the proportion of axons in the corpus callosum that were myelinated in Scribble cKO compared to wild-type animals (A–C). Fewer remyelinated axons were observed in corpus callosum in the lesion area in Scribble cKO mice (E) relative to controls (D) as quantified in F; 0.4–0.5 μm: WT = 80.0% ± 9.8%, cKO = 41.3% ± 8.9% myelinated; 0.5–0.6 μm: WT = 79.4% ± 6.3%, cKO = 41.5% ± 9.5% myelinated; 0.6–0.7 μm: WT = 91.6% ± 3.0%, cKO = 44.3% ± 8.7% myelinated; >0.7 μm: WT = 92.7% ± 1.9%, cKO = 47.9% ± 2.5% myelinated. …”
  6. 1646
  7. 1647
  8. 1648
  9. 1649
  10. 1650
  11. 1651
  12. 1652

    Decreased Serum Level of miR-146a as Sign of Chronic Inflammation in Type 2 Diabetic Patients by Lucy Baldeón R. (674016)

    Published 2014
    “…</p><p></p><p></p><p>Conclusions</p><p>This study shows decreased serum anti-inflammatory miR-146a, increased pro-inflammatory IL-8 and increased HGF (a vascular/insular repair factor) as discriminating markers of failure of glucose control occurring on the background of obesity and dyslipidemia.…”
  13. 1653
  14. 1654
  15. 1655

    CC genotype of rs7120118 variation associates with decreased soluble Aβ42 levels in the temporal cortex. by Teemu Natunen (398069)

    Published 2013
    “…(B) Aβ42-ELISA demonstrates a significant decrease in the soluble Aβ42 levels in the temporal cortex of patients with CC genotype as compared to the TT genotype (*p<0.05, ANOVA LSD, n = 33/34/16, rs7120118 genotypes TT/CT/CC, respectively). …”
  16. 1656
  17. 1657
  18. 1658
  19. 1659
  20. 1660